Loading clinical trials...
Loading clinical trials...
The objective of the ENVIsIoN study is to collect data on the use of the VERAFEYE navigation and imaging system in patients indicated to undergo a catheter ablation procedure for the treatment of Paro...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
LUMA Vision Ltd.
NCT07421076 · Paroxysmal Atrial Fibrillation (PAF)
NCT05988411 · Paroxysmal Atrial Fibrillation, Persistent Atrial Fibrillation
NCT07281898 · Paroxysmal Atrial Fibrillation
NCT06765356 · Persistent Atrial Fibrillation, Paroxysmal Atrial Fibrillation, and more
NCT06106594 · Atrial Arrhythmia, Atrial Fibrillation, and more
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions